UK Markets closed
NIKKEI 225
26,945.67 -388.12 (-1.42%) HANG SENG
19,258.76 +258.05 (+1.36%) CRUDE OIL
69.50 +0.17 (+0.25%) GOLD FUTURES
1,943.80 +2.70 (+0.14%) DOW
32,560.60 +316.02 (+0.98%) BTC-GBP
22,958.57 +47.31 (+0.21%)
SWEDISH ORPHAN BIOVIT.SK1 (B6E.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CET
| Previous close | 21.24 |
| Open | 21.65 |
| Bid | 21.41 x N/A |
| Ask | 21.72 x N/A |
| Day's range | 21.65 - 21.65 |
| 52-week range | 18.38 - 22.78 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Apellis' (APLS) Earnings Top, Empaveli Sales Boost Revenues
Apellis Pharmaceuticals (APLS) reports better-than-expected results, beating both earnings and revenue estimates. Empaveli sales continue to boost product revenues for the company.
- Zacks
Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year?
Here is how Alimera Sciences (ALIM) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.
© 2023 Yahoo. All rights reserved.
